321 related articles for article (PubMed ID: 24053474)
1. Gene expression modifications in Wharton's Jelly mesenchymal stem cells promoted by prolonged in vitro culturing.
Gatta V; D'Aurora M; Lanuti P; Pierdomenico L; Sperduti S; Palka G; Gesi M; Marchisio M; Miscia S; Stuppia L
BMC Genomics; 2013 Sep; 14():635. PubMed ID: 24053474
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.
Cardoso TC; Ferrari HF; Garcia AF; Novais JB; Silva-Frade C; Ferrarezi MC; Andrade AL; Gameiro R
BMC Biotechnol; 2012 May; 12():18. PubMed ID: 22559872
[TBL] [Abstract][Full Text] [Related]
4. A GMP-compliant manufacturing method for Wharton's jelly-derived mesenchymal stromal cells.
Chu W; Zhang F; Zeng X; He F; Shang G; Guo T; Wang Q; Wu J; Li T; Zhong ZZ; Liang X; Hu J; Liu M
Stem Cell Res Ther; 2024 May; 15(1):131. PubMed ID: 38702793
[TBL] [Abstract][Full Text] [Related]
5. Positive selection of Wharton's jelly-derived CD105(+) cells by MACS technique and their subsequent cultivation under suspension culture condition: A simple, versatile culturing method to enhance the multipotentiality of mesenchymal stem cells.
Amiri F; Halabian R; Dehgan Harati M; Bahadori M; Mehdipour A; Mohammadi Roushandeh A; Habibi Roudkenar M
Hematology; 2015 May; 20(4):208-16. PubMed ID: 25116042
[TBL] [Abstract][Full Text] [Related]
6. Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton's jelly-derived mesenchymal stem cells.
Corotchi MC; Popa MA; Remes A; Sima LE; Gussi I; Lupu Plesu M
Stem Cell Res Ther; 2013 Jul; 4(4):81. PubMed ID: 23845279
[TBL] [Abstract][Full Text] [Related]
7. Treatment With Human Wharton's Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction.
Cóndor JM; Rodrigues CE; Sousa Moreira Rd; Canale D; Volpini RA; Shimizu MH; Camara NO; Noronha Ide L; Andrade L
Stem Cells Transl Med; 2016 Aug; 5(8):1048-57. PubMed ID: 27280799
[TBL] [Abstract][Full Text] [Related]
8. Improving stemness and functional features of mesenchymal stem cells from Wharton's jelly of a human umbilical cord by mimicking the native, low oxygen stem cell niche.
Obradovic H; Krstic J; Trivanovic D; Mojsilovic S; Okic I; Kukolj T; Ilic V; Jaukovic A; Terzic M; Bugarski D
Placenta; 2019 Jul; 82():25-34. PubMed ID: 31174623
[TBL] [Abstract][Full Text] [Related]
9. Wharton's Jelly Mesenchymal Stromal Cells from Human Umbilical Cord: a Close-up on Immunomodulatory Molecules Featured In Situ and In Vitro.
Corsello T; Amico G; Corrao S; Anzalone R; Timoneri F; Lo Iacono M; Russo E; Spatola GF; Uzzo ML; Giuffrè M; Caprnda M; Kubatka P; Kruzliak P; Conaldi PG; La Rocca G
Stem Cell Rev Rep; 2019 Dec; 15(6):900-918. PubMed ID: 31741193
[TBL] [Abstract][Full Text] [Related]
10. Molecular and Functional Verification of Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs) Pluripotency.
Musiał-Wysocka A; Kot M; Sułkowski M; Badyra B; Majka M
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013696
[TBL] [Abstract][Full Text] [Related]
11. Compared to the amniotic membrane, Wharton's jelly may be a more suitable source of mesenchymal stem cells for cardiovascular tissue engineering and clinical regeneration.
Pu L; Meng M; Wu J; Zhang J; Hou Z; Gao H; Xu H; Liu B; Tang W; Jiang L; Li Y
Stem Cell Res Ther; 2017 Mar; 8(1):72. PubMed ID: 28320452
[TBL] [Abstract][Full Text] [Related]
12. Wharton's Jelly Derived-Mesenchymal Stem Cells: Isolation and Characterization.
Ranjbaran H; Abediankenari S; Mohammadi M; Jafari N; Khalilian A; Rahmani Z; Momeninezhad Amiri M; Ebrahimi P
Acta Med Iran; 2018 Jan; 56(1):28-33. PubMed ID: 29436792
[TBL] [Abstract][Full Text] [Related]
13. AFM-based Analysis of Wharton's Jelly Mesenchymal Stem Cells.
Szydlak R; Majka M; Lekka M; Kot M; Laidler P
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491893
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Long-Term in vitro Multiplied Human Wharton's Jelly-Derived Mesenchymal Stem Cells prior to Their Use in Clinical Administration.
Panwar U; Mishra K; Patel P; Bharadva S; Vaniawala S; Shah A; Vundinti BR; Kothari SL; Ghosh K
Cells Tissues Organs; 2021; 210(4):239-249. PubMed ID: 34521091
[TBL] [Abstract][Full Text] [Related]
15. Effect of human Wharton's jelly mesenchymal stem cell paracrine signaling on keloid fibroblasts.
Arno AI; Amini-Nik S; Blit PH; Al-Shehab M; Belo C; Herer E; Jeschke MG
Stem Cells Transl Med; 2014 Mar; 3(3):299-307. PubMed ID: 24436441
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of human umbilical cord Wharton's jelly-derived mesenchymal stem cells into endometrial cells.
Shi Q; Gao J; Jiang Y; Sun B; Lu W; Su M; Xu Y; Yang X; Zhang Y
Stem Cell Res Ther; 2017 Nov; 8(1):246. PubMed ID: 29096715
[TBL] [Abstract][Full Text] [Related]
17. Wharton's Jelly Mesenchymal Stromal Cells Support the Expansion of Cord Blood-derived CD34
Lo Iacono M; Russo E; Anzalone R; Baiamonte E; Alberti G; Gerbino A; Maggio A; La Rocca G; Acuto S
Cell Transplant; 2018 Jan; 27(1):117-129. PubMed ID: 29562783
[TBL] [Abstract][Full Text] [Related]
18. Pluripotent gene expression in mesenchymal stem cells from human umbilical cord Wharton's jelly and their differentiation potential to neural-like cells.
Tantrawatpan C; Manochantr S; Kheolamai P; U-Pratya Y; Supokawej A; Issaragrisil S
J Med Assoc Thai; 2013 Sep; 96(9):1208-17. PubMed ID: 24163998
[TBL] [Abstract][Full Text] [Related]
19. Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.
Devito L; Badraiq H; Galleu A; Taheem DK; Codognotto S; Siow R; Khalaf Y; Briley A; Shennan A; Poston L; McGrath J; Gentleman E; Dazzi F; Ilic D
Regen Med; 2014; 9(6):723-32. PubMed ID: 25431909
[TBL] [Abstract][Full Text] [Related]
20. Scaffold-free 3D culturing enhance pluripotency, immunomodulatory factors, and differentiation potential of Wharton's jelly-mesenchymal stem cells.
Thakur G; Bok EY; Kim SB; Jo CH; Oh SJ; Baek JC; Park JE; Kang YH; Lee SL; Kumar R; Rho GJ
Eur J Cell Biol; 2022; 101(3):151245. PubMed ID: 35667339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
